Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet
Descrição
![Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet](https://pub.mdpi-res.com/ijerph/ijerph-17-08541/article_deploy/html/images/ijerph-17-08541-g001-550.jpg?1605673613)
IJERPH, Free Full-Text
![Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet](https://www.obgproject.com/wp-content/uploads/2019/03/manja-vitolic-586192-unsplash-featured.jpg)
Severe Hypertension in Pregnancy: Which Oral Medication is Optimal When IV Access is Limited? - The ObG Project
![Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet](https://storage.googleapis.com/jnl-up-j-mdbcj-files/journals/1/articles/696/submission/proof/696-10-3456-1-17-20210924.png)
Prevention Starts in the Womb: Opportunities for Addressing Cardiovascular Risk Factors During Pregnancy and Beyond - Methodist DeBakey Cardiovascular J
![Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet](https://lib.medvestnik.ru/apps/lib/assets/uploads/aig/2023/01/eng/55-2.jpg)
Comparative analysis of the effect of two antihypertensive therapy regimens on maternal hemodynamic parameters in early- and late-onset preeclampsia » Obstetrics and Gynecology
![Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet](https://obgyn.onlinelibrary.wiley.com/cms/asset/7b9ff59d-e03e-4508-bd78-99cc453015d5/ijgo.v154.s1.cover.jpg)
A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre‐eclampsia - Poon - 2021 - International Journal of Gynecology & Obstetrics - Wiley Online Library
Full article: Selecting emergency therapy for patients with pre-eclampsia
![Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet](https://europepmc.org/articles/PMC9474278/bin/228_2022_3382_Fig1_HTML.jpg)
Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review. - Abstract - Europe PMC
![Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41572-023-00417-6/MediaObjects/41572_2023_417_Fig4_HTML.png)
Pre-eclampsia Nature Reviews Disease Primers
![Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet](https://f1000research.s3.amazonaws.com/manuscripts/144510/c94b61c9-4e10-4f2d-ab78-d37b250e219d_figure2.gif)
Effectiveness of nifedipine, labetalol, and
![Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet](https://d3i71xaburhd42.cloudfront.net/561a90a208c4b886aa426e615dc0c1038e7d4150/5-Table1-1.png)
PDF] Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open- label, randomised controlled trial
![Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary-alt:20211119064611-45122-mediumThumb-49578fig25_1.jpg?pub-status=live)
Hypertensive Disorders in Pregnancy and Eclampsia (Chapter 25) - The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology
![Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary-alt:20211119064611-30825-mediumThumb-49578fig32_2.jpg?pub-status=live)
Maternal Medicine (Section 4) - The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology
![Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002252.pub4/media/CDSR/CD002252/image_n/nCD002252-CMP-005-19.png)
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy - Abalos, E - 2018
de
por adulto (o preço varia de acordo com o tamanho do grupo)